Stryker Corporation (SYK) New York Stock Exchange
160.110.000.00%
Previous closeDecember 17, 2018

News: updated – 18-Dec 09:35


Credit Suisse sees 18% upside in Abbott in premarket analyst action18-Dec 08:05(SeekingAlpha)

Abbott (NYSE: ABT ) initiated with Outperform rating and $82 (18% upside) price target at Credit Suisse. More news on: Abbott Laboratories, Alnylam Pharmaceuticals, Inc., Baxter International Inc, Healthcare stocks news, Stocks on the move, , Read more …

Penumbra Should Shine Brighter12-Dec 10:34(SeekingAlpha)

I loved just about everything about Penumbra ( PEN ) except the price/upside when I last wrote about this fast-growing neurovascular med-tech company. Since then, the company has continued to sail past sell-side expectations, but the market has gotten more risk-averse and worries have crop…